Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-Verapamil for Episodic Cluster Headache
NCT02209155Phase 2Terminated
- Sponsor
- Center Laboratories, Inc.
- Start
- Nov 2013
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexverapamil in Cluster Headache (CH), sponsored by Center Laboratories, Inc.. Started Nov 2013; status: terminated.
02
Drugs
dexverapamil
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT02209155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209155.